Our senior management team provide a breadth of industrial, academic and CRO experience, across formulations, manufacturing, analytical and materials science.
We have delivered over 1500 projects working on more than 20 blockbuster products while ensuring fast and effective delivery of our clients’ individual needs.
Dr. Martyn Davies has served as Advisor to Juniper Pharmaceuticals’ Board of Directors since September 2013. He co-founded Molecular Profiles Ltd (now known as Juniper Pharma Services) as a spin-out company from his academic laboratory in 1997 serving as Founder-Chairman until September 2013. Dr. Davies has played a key role in the strategic development of the company and also in leading and consulting on many technical projects for clients.
Dr. Davies has over 30 years’ experience in pharmaceutical, biopharmaceutical and drug delivery fields. He is also an Emeritus Professor at the University of Nottingham’s School of Pharmacy and holds a first class honours degree in Pharmacy from Brighton Polytechnic and a Ph.D. from Kings College, University of London.
Dr. Davies has authored or co-authored more than 425 scientific articles, is a Fellow of the Royal Society for Chemistry and Royal Pharmaceutical Society of Great Britain, and a past President of the Controlled Release Society (2011-12).
In December 2017, Dr Davies was appointed as a Commander of the Order of the British Empire (CBE) in recognition of his contribution to science and his achievements in pharmaceutical research and drug development.
Dr. Nikin Patel co-founded and is the former Chief Executive Officer of Molecular Profiles (now known as Juniper Pharma Services). He joined our board of directors in September 2013 when Molecular Profiles was acquired by Juniper Pharmaceuticals (formerly Columbia Laboratories). Dr. Patel has over 20 years’ management and technical experience centered on pharmaceutical analysis and formulation development. His leadership was recognized externally through the U.K.’s most prestigious industry accolade, the Queen’s Award for Enterprise, won by Molecular Profiles in both 2007 and 2011 in the Innovation category.
Dr. Patel holds a first class honours degree and PhD in Pharmacy from the University of Nottingham, and is a Member of the Royal Pharmaceutical Society (MRPharmS). Dr. Patel is also a co-founder of Locate Therapeutics, a specialist regenerative medicine and device company and was a director from 2001 through 2014.
Chief Scientific Officer
Dr. Shen Luk has over 20 years of technical experience in the pharmaceutical and chemical industries. Since joining, in 2000, Dr. Luk has been integral in developing the company’s scientific breadth and rigor. He leads and consults on a diverse array of analytical, characterization and pharmaceutical development projects. Over the past decade, Dr. Luk has also used his extensive analytical and characterization expertise for pharmaceutical systems to assist and consult in litigation matters surrounding intellectual property. Previously, Dr. Luk spent ten years working in the chemicals industry at Courtalds Corporate Research Laboratories.
Dr. Luk holds a Chemistry degree and doctorate from the University of Manchester’s Institute of Science and Technology.
VP Commercial Services
Dr. Claire Madden-Smith has served at Juniper Pharma Services for over a decade. She brings over 15 years of CRO business and technical experience, leading our commercial team and pharmaceutical development service. Dr. Madden-Smith instills a consultative approach to the development of new business opportunities.Dr. Madden-Smith holds a degree in Chemistry and a doctorate in Physical Chemistry from Loughborough University. Previously she has chaired the Marketing Committee of the Controlled Release Society and served on the Materials Science focus group of the Academy of Pharmaceutical Science GB.
Chief Technical Officer
Dr. Robert Harris has held the role of Chief Technical Officer at Juniper Pharma Services since 2010, providing technical steer to our formulation development and clinical trial manufacturing services. Dr. Harris, has over 30 years of pharmaceutical industrial experience. Working in GMP environments for both commercial and investigational medicinal products at blue chip, SME and CRO companies, Dr. Harris has successfully managed the development of over 50 new chemical entities. He also brings extensive expertise in the on-time delivery of clinical trial materials for contract research services.